Neoplasia/BPH

	Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial. Eur Urol El-Taji O, Dutey-Magni P, Brown M, Murray M, Amos C, Gilbert D, Parmar M, Brown L, Sydes M, Attard G, James N, Clarke NW, Sachdeva A, STAMPEDE Collaborators. PMID: 42838799 [PubMed - as supplied by publisher]
	Adamantinoma-like Ewing sarcoma of the bladder. BMJ Case Rep Cronin C, Lokeshwar SD, Calagua C, Garman TS, Kates M, Aragon-Ching JB, Benyounes A, Smith AK. PMID: 42838705 [PubMed - indexed for MEDLINE]
	Superhydrophobic micro-structural substrate for renal cell carcinoma detection using LIBS-FTIR dual-spectra. Anal Chim Acta Chen W, Huang W, Li F, Guo L. PMID: 42838663 [PubMed - indexed for MEDLINE]
	Metastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA. BMJ Open Lichtman-Mikol S, Lang JM, Nagar H, Zuhour R, Chaung KV, Zaorsky NG, Roy S, Mendiratta PM, Shoag JE, Janopaul-Naylor JR, Khani F, Schaeffer EM, Kyriakopoulos CE, Barata P, Brown JR, Garcia JA, Barbieri CE, Sun Y, Choyke PL, Spratt DE, Jia AY. PMID: 42838582 [PubMed - indexed for MEDLINE]
	The Impact of the Tumor Microenvironment on Immune Checkpoint Inhibitor Resistance in Prostate Cancer: Mechanistic Insights and Therapeutic Strategies. Crit Rev Oncol Hematol Zhou S, Bi Y, Xiong Z, Guo Y, Cui X, Zhang M. PMID: 42838467 [PubMed - as supplied by publisher]
	Impact on renal function, tumor volume, and complications of transarterial embolization for renal angiomyolipomas: An Evidence-Based systematic review and meta-analysis. J Vasc Interv Radiol Orra AF, Orra SH, Nabhan Martinez JV, Pinhata Otoch J, Shiomi da Cruz JA. PMID: 42838444 [PubMed - as supplied by publisher]
	SUMOylation and palmitoylation in metastatic prostate cancer: A compartment-based framework for nuclear and membrane adaptation. Biochem Biophys Res Commun Ji S, Li S, Wei Y, Zhu Q. PMID: 42837809 [PubMed - as supplied by publisher]
	Anticoagulation management and outcomes in cancer-associated gonadal and renal vein thrombosis: A multicenter retrospective cohort study. Thromb Res Butera E, Cavallaro C, D'Errico A, Talerico R, Mallick R, Kou R, Carrier M, Pola R, Wang TF. PMID: 42837788 [PubMed - as supplied by publisher]
	Effect of Marital Status on Longer Time from Diagnosis to External Beam Radiation Therapy in High-Risk Prostate Cancer Patients According to Race/Ethnicity. J Racial Ethn Health Disparities Quarta L, Polverino F, Petix M, Filzmayer M, Orlandi F, Goyal JA, Longo N, Ferro M, Chun FKH, Micali S, Shariat SF, Barletta F, Stabile A, Gandaglia G, Montorsi F, Saad F, Briganti A, Karakiewicz PI. PMID: 42837102 [PubMed - as supplied by publisher]
	Recent advances in discriminating prostate cancer from benign prostatic diseases in the pre-biopsy population. Med Oncol Nie Z, Zhu T, Chen Y, Zhang W, Wu L. PMID: 42837038 [PubMed - indexed for MEDLINE]
	Very Important Person (VIP) Syndrome: Psychological Illusion or Real Surgical Risk? A Propensity Score-Matched Cohort Study of Robot-Assisted Radical Prostatectomy With a Surgeon Survey. J Eval Clin Pract Park T, Lee H, Kim TB, Chung KJ, Kim CH, Kim KT, Park IW. PMID: 42836826 [PubMed - indexed for MEDLINE]
	Extrarenal TFE3-Rearranged Renal Cell Carcinoma: Diagnostic Challenges in an Uncommon Scalp Localization. Turk Patoloji Derg Tazi I, Allaoui M, El-Ochi MR, Mustapha A, Damiri A, Elktaibi A, Essaoudi A, Chahdi H, Oukabli M. PMID: 42836579 [PubMed - as supplied by publisher]
	The safety and efficacy of metformin on metabolic syndrome parameters in prostate cancer patients receiving androgen deprivation therapy: A systematic review and meta-analysis. Arab J Urol Alharran AM, Alsaid MA, Hussain AA, Aladwani FA, Alaradi H. PMID: 42836214 [PubMed]
	Shared decision-making experiences regarding urinary diversion among Chinese patients with muscle-invasive bladder cancer: A qualitative study. Asia Pac J Oncol Nurs Zhu K, Zhang Y, Wang Y, Chen L, Qiao W, Tan M, Liu J, Li K, Hou S. PMID: 42835880 [PubMed]
	Minimum ADC outperforms PSA and PSA density for predicting ISUP grade group in prostate cancer: a retrospective study of 192 patients undergoing radical prostatectomy. Front Oncol Skrobisz K, Bernard W, Bromirski R, Nowak K, Gli, Po, Pie. PMID: 42835434 [PubMed]
	Early insulin combined with metformin therapy and long-term risks of cardiovascular disease, kidney disease, and cancer in newly diagnosed type 2 diabetes: a real-world cohort study in China. Front Endocrinol (Lausanne) Yan L, Luo Q, Wang J, Zhang S, Xu R, Lv M, Su P, Zhang S, Ji X, Zhu G, Xue F. PMID: 42835393 [PubMed - indexed for MEDLINE]
	Exploring cheminformatics tools to combat prostate cancer: diagnostics, therapeutics, and mechanistic studies. In Silico Pharmacol Igwe S, Ehi-Eromosele CO, Udofia IA, Oloba-Whenu OA. PMID: 42835226 [PubMed]
	MRI-based habitat radiomics analysis for predicting clinically significant prostate cancer: a retrospective dual-center study. Front Oncol Chen Z, Ye Y, Peng Y, Gong Z, Liu Z, Xiang X, Liao Y, Gong L. PMID: 42835136 [PubMed]
	Practical deep learning solutions for prostate cancer segmentation and implementation in radiotherapy planning. Phys Eng Sci Med Hizam DA, Saad M, Ung NM, Muaadz A, Salleh FM, Tan LK. PMID: 42834307 [PubMed - as supplied by publisher]
	Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.04.013. Eur Urol Stabile A, Quarta L, Scilipoti P, Dehò F, Briganti A, Montorsi F. PMID: 42833933 [PubMed - as supplied by publisher]

Articles 1 - 20 / 191835

Page 1 of 9592



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy